Your browser is no longer supported. Please, upgrade your browser.
Settings
ICUI ICU Medical, Inc. daily Stock Chart
ICUI [NASD]
ICU Medical, Inc.
Index- P/E48.10 EPS (ttm)3.86 Insider Own1.70% Shs Outstand20.88M Perf Week-3.04%
Market Cap3.82B Forward P/E24.83 EPS next Y7.48 Insider Trans-18.72% Shs Float19.57M Perf Month1.63%
Income82.90M PEG3.01 EPS next Q1.31 Inst Own95.00% Short Float1.42% Perf Quarter7.49%
Sales1.26B P/S3.04 EPS this Y242.00% Inst Trans0.17% Short Ratio1.97 Perf Half Y-2.12%
Book/sh67.61 P/B2.74 EPS next Y16.80% ROA4.70% Target Price222.67 Perf Year16.18%
Cash/sh22.39 P/C8.29 EPS next 5Y16.00% ROE6.00% 52W Range148.89 - 236.51 Perf YTD-0.83%
Dividend- P/FCF46.97 EPS past 5Y22.70% ROI6.80% 52W High-21.54% Beta0.64
Dividend %- Quick Ratio2.00 Sales past 5Y32.60% Gross Margin36.70% 52W Low24.64% ATR6.51
Employees8000 Current Ratio2.90 Sales Q/Q-2.80% Oper. Margin7.70% RSI (14)42.34 Volatility4.38% 3.60%
OptionableYes Debt/Eq0.11 EPS Q/Q-17.10% Profit Margin6.60% Rel Volume1.09 Prev Close189.38
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout0.00% Avg Volume140.82K Price185.57
Recom2.00 SMA20-4.15% SMA50-2.01% SMA200-3.65% Volume152,884 Change-2.01%
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
Feb-10-15Reiterated ROTH Capital Buy $82 → $96
Nov-11-14Upgrade ROTH Capital Neutral → Buy $56 → $82
May-09-13Downgrade The Benchmark Company Buy → Hold
Sep-27-12Reiterated The Benchmark Company Buy $60 → $69
Apr-12-12Initiated The Benchmark Company Buy $60
Sep-26-11Reiterated Ticonderoga Buy $52 → $49
Oct-29-09Initiated C.K. Cooper Buy $45
Oct-08-09Initiated Roth Capital Hold $40
Mar-05-09Initiated Northland Securities Outperform
May-02-08Initiated Jesup & Lamont Buy $35
Mar-26-08Initiated Soleil Buy
Sep-14-20 10:53PM  
Sep-11-20 09:36AM  
Sep-08-20 07:30AM  
Aug-19-20 01:15PM  
Aug-12-20 08:30AM  
Aug-10-20 09:00PM  
04:05PM  
04:00PM  
Aug-07-20 08:46AM  
Aug-03-20 12:31PM  
Jul-27-20 11:23AM  
Jul-20-20 12:14PM  
Jul-15-20 07:30AM  
Jun-17-20 11:35AM  
Jun-16-20 04:18PM  
Jun-15-20 09:31AM  
Jun-10-20 01:21PM  
Jun-08-20 05:56PM  
12:53PM  
Jun-05-20 08:44AM  
Jun-04-20 11:18AM  
Jun-03-20 04:21PM  
Jun-02-20 03:05PM  
May-28-20 04:53PM  
03:58PM  
01:40PM  
May-27-20 07:25PM  
06:30PM  
08:18AM  
May-25-20 03:00PM  
May-22-20 06:24PM  
May-21-20 04:20PM  
May-20-20 01:19PM  
May-19-20 07:00PM  
05:00PM  
02:54PM  
May-15-20 03:49PM  
11:42AM  
May-14-20 02:45PM  
May-08-20 02:30PM  
12:17PM  
04:46AM  
May-07-20 04:05PM  
Apr-30-20 12:33PM  
Apr-20-20 09:14AM  
07:30AM  
Apr-09-20 08:27AM  
Apr-02-20 01:00PM  
Apr-01-20 09:27AM  
Mar-27-20 02:53PM  
Mar-19-20 08:11AM  
Mar-06-20 10:18AM  
Mar-04-20 09:53AM  
Feb-28-20 11:45AM  
Feb-27-20 07:25PM  
04:05PM  
Feb-20-20 12:31PM  
Feb-13-20 08:54AM  
Feb-06-20 07:30AM  
Feb-04-20 04:23AM  
Jan-18-20 09:15AM  
Jan-07-20 04:05PM  
Dec-23-19 08:54AM  
Dec-12-19 01:43PM  
Dec-06-19 02:26PM  
Dec-02-19 04:14PM  
Nov-27-19 07:18AM  
Nov-11-19 05:25PM  
04:05PM  
Nov-05-19 08:03AM  
Nov-04-19 10:30AM  
07:00AM  
Oct-30-19 02:00PM  
Oct-28-19 11:01AM  
Oct-22-19 07:30AM  
Oct-14-19 08:16PM  
Oct-08-19 08:06AM  
Oct-07-19 04:15PM  
Sep-18-19 09:05AM  
Sep-13-19 05:54PM  
Sep-09-19 07:00AM  
Aug-30-19 10:31AM  
Aug-29-19 10:06AM  
07:42AM  
Aug-08-19 12:06AM  
Aug-07-19 07:55PM  
04:02PM  
Aug-03-19 10:44AM  
Jul-31-19 10:36AM  
Jul-17-19 07:30AM  
Jul-08-19 05:00PM  
Jul-04-19 09:37AM  
Jun-23-19 04:11PM  
Jun-01-19 10:33AM  
May-21-19 01:34AM  
May-09-19 10:54PM  
07:55PM  
06:51PM  
04:05PM  
May-08-19 01:12PM  
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGrody Kevin JChief Accounting OfficerSep 01Option Exercise0.0057202,632Sep 02 12:18 PM
Jain VivekChairman and CEOSep 01Option Exercise58.7911,500676,08577,681Sep 03 04:45 PM
Jain VivekChairman and CEOSep 01Sale197.1711,5002,267,48766,181Sep 03 04:45 PM
Jain VivekChairman and CEOAug 27Option Exercise58.7911,500676,08577,681Aug 28 05:27 PM
Jain VivekChairman and CEOAug 27Sale195.0011,5002,242,50066,181Aug 28 05:27 PM
Bonnell Brian MichaelChief Financial OfficerAug 14Option Exercise0.001,20801,553Aug 14 06:11 PM
FINNEY ELISHA WDirectorAug 13Sale190.00790150,1001,483Aug 13 05:18 PM
SWINNEY ROBERT SDirectorJul 16Option Exercise37.001,50055,50021,582Jul 16 05:40 PM
SWINNEY ROBERT SDirectorJul 16Sale188.4630056,53821,282Jul 16 05:40 PM
LOPEZ GEORGE ADirectorJun 09Sale194.898,8001,715,010339,764Jun 10 06:24 PM
LOPEZ GEORGE ADirectorJun 08Sale203.111,200243,736339,764Jun 10 06:24 PM
LOPEZ GEORGE ADirectorJun 03Sale199.009,3311,856,869339,764Jun 04 07:38 PM
LOPEZ GEORGE ADirectorJun 02Sale200.294,118824,796339,764Jun 04 07:38 PM
Jain VivekChairman and CEOJun 01Sale203.8715,0003,058,05266,211Jun 03 04:59 PM
LOPEZ GEORGE ADirectorMay 28Sale197.3716,5513,266,738329,651Jun 01 04:51 PM
Hoffmeister David FDirectorMay 13Option Exercise0.003780693May 14 03:59 PM
Greenberg David C.DirectorMay 13Option Exercise0.0037802,703May 14 12:25 PM
SWINNEY ROBERT SDirectorMay 13Option Exercise0.00378020,082May 14 12:18 PM
FINNEY ELISHA WDirectorMay 13Option Exercise0.0037802,273May 14 03:50 PM
Abbey DonaldDirectorMay 13Option Exercise0.003780693May 14 12:54 PM
SWINNEY ROBERT SDirectorApr 06Sale207.151,500310,72519,704Apr 06 05:13 PM
Woolson DanielVP, GM-Infusion CapitalMar 27Option Exercise0.0024306,247Mar 30 11:43 AM
Voigtlander Christian B.Chief Operating OfficerMar 27Option Exercise0.0059308,154Mar 30 11:39 AM
Sanzone Virginia RuthVP, General CounselMar 27Option Exercise0.0059301,809Mar 30 11:35 AM
Jain VivekChairman and CEOMar 27Option Exercise0.001,933082,290Mar 30 11:31 AM
McGrody Kevin JChief Accounting OfficerMar 27Option Exercise0.0064702,400Mar 30 11:27 AM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.002,61608,320Mar 10 03:46 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.001,44306,643Mar 10 03:34 PM
Jain VivekChairman and CEOMar 06Option Exercise0.004,124081,116Mar 10 03:26 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.001,44301,975Mar 10 03:21 PM
McGrody Kevin JChief Accounting OfficerMar 06Option Exercise0.001,68002,284Mar 10 03:15 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.007220722Mar 10 02:59 PM
Lamb Scott EChief Financial Officer,Feb 14Option Exercise0.001,006016,803Feb 14 06:56 PM
Sanzone Virginia RuthVP, General CounselFeb 14Option Exercise0.001,00601,061Feb 14 06:48 PM
Woolson DanielVP, GM-Infusion CapitalFeb 14Option Exercise0.0080505,556Feb 14 06:43 PM
Woolson DanielVP, GM-Infusion CapitalFeb 13Option Exercise0.002,28204,751Feb 14 06:43 PM
Sanzone Virginia RuthVP, General CounselFeb 03Sale182.132,487452,95755Feb 03 05:17 PM
SWINNEY ROBERT SDirectorJan 30Sale184.0726849,33119,704Jan 30 05:23 PM
McCall Thomas DVice President and Gen'l Mgr.Jan 17Option Exercise0.003,15309,539Jan 21 01:59 PM
Jain VivekChairman and CEOJan 17Option Exercise0.0017,934087,879Jan 21 01:02 PM
Woolson DanielVP, GM-Infusion CapitalJan 17Option Exercise0.002,18104,478Jan 21 02:49 PM
Voigtlander Christian B.Chief Operating OfficerJan 17Option Exercise0.005,33409,166Jan 21 01:41 PM
Sanzone Virginia RuthVP, General CounselJan 17Option Exercise0.005,33405,389Jan 21 01:19 PM
Lamb Scott EChief Financial Officer,Jan 17Option Exercise0.005,334018,643Jan 21 01:46 PM
Lamb Scott EChief Financial Officer,Dec 10Sale177.9420,8153,703,81413,309Dec 10 05:29 PM
Lamb Scott EChief Financial Officer,Dec 09Sale180.589,1851,658,59913,309Dec 10 05:29 PM
LOPEZ GEORGE ADirectorDec 06Sale186.13623115,958348,864Dec 09 04:55 PM
LOPEZ GEORGE ADirectorDec 05Sale184.2412,9392,383,826348,864Dec 09 04:55 PM
LOPEZ GEORGE ADirectorDec 03Sale184.2920,0003,685,831348,864Dec 03 06:21 PM
SWINNEY ROBERT SDirectorOct 14Sale153.4937357,25218,472Oct 15 12:28 PM